Cryoniss
London, United Kingdom· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Develops advanced cell and regenerative therapies for degenerative conditions and tissue repair.
Regenerative MedicineOrthopedicsNeurology
Technology Platform
A platform for developing 'living' cell-based therapies, focusing on cell sourcing, engineering, cryopreservation, and delivery to enable tissue repair and regeneration.
Opportunities
Significant unmet medical need in degenerative diseases and supportive regulatory pathways for advanced therapies in the UK/EU provide a clear development roadmap.
Risk Factors
Faces substantial scientific risks related to cell engraftment, durability, and safety, alongside formidable challenges in scalable, cost-effective manufacturing.
Competitive Landscape
Competes in the high-potential but risky cell therapy sector against numerous biotechs and academic spin-outs, all racing to solve challenges in cell manufacturing, delivery, and efficacy.